NYSE : BMY

Bristol-Myers Squibb Company

Healthcare · Drug Manufacturers - General · United States

Last price 62.48 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 127.71B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the ...